Targeting bile‐acid signalling for metabolic diseases
Open accessThe DOI matches its Crossref record; 165 of the 169 references it cites were found in a registry or an index.
Abstract
Bile acids are increasingly being appreciated as complex metabolic integrators and signalling factors and not just as lipid solubilizers and simple regulators of bile-acid homeostasis. It is therefore not surprising that a number of bile-acid-activated signalling pathways have become attractive therapeutic targets for metabolic disorders. Here, we review how the signalling functions of bile acids can be exploited in the development of drugs for obesity, type 2 diabetes, hypertriglyceridaemia and atherosclerosis, as well as other associated chronic diseases such as non-alcoholic steatohepatitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Through FXR activation, OCA modulates bile acid synthesis, absorption, transport, secretion, and metabolism, with a net effect of choleresis.(157,158)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“In animal models, FXR activation has demonstrated antifibrotic and anti-inflammatory properties as well.(157)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“After conjugation with either taurine or glycine, primary bile acids are released into the intestine to assist with lipid digestion and are recycled back into the liver (Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“By activating nuclear farnesoid X receptor (FXR) and plasma membrane TGR5 receptor, bile acids were shown to regulate systemic lipid, cholesterol, and glucose metabolism, as well as energy and immune homeostasis (Calmus and Poupon, 2014;de Aguiar Vallim et al., 2013;Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“In addition, FXR regulates other pathways with direct antiinflammatory and antifibrotic effects. 13-15”
From A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis (2016) · cites this paper as [13]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Self-citationThe Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Research works printed but not linked: 1
- Harnish, D. C. et al. A synthetic farnesoid X receptor (FXR) agonist protects against diet-induced dyslipidemia. J. Clin. Lipidol. 1, 362 (2007).
Cited by
Items 701–800 of 1,002
Marion, T. L., Perry, C. H., Claire, R. L. S., Yue, W., & Brouwer, K. L. R. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr014 · Cited by 24
“The hydrophobicity of individual BAs is inversely proportional to the number and orientation of hydroxyl groups on the steroid nucleus and is predictive of toxicity (reviewed in Thomas et al., 2008).”
BackgroundAoki, M., Konya, Y., Takagaki, T., Umemura, K., Sogame, Y., Katsumata, T., & Komuro, S. (2011) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.5072 · Cited by 27
Gut-lung immunometabolic crosstalk in sepsis: from microbiota to respiratory failure
Li, Q., Song, X.-C., Li, K., & Wang, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1685044 · Cited by 34
The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes
Schaffner, C. A. M., Mwinyi, J., Gai, Z., Thasler, W. E., Eloranta, J. J., & Kullak-Ublick, G. A. (2014) · Liver International · doi:10.1111/liv.12558 · Cited by 22
“The nuclear farnesoid X receptor (FXR), also known as the bile acid receptor (BAR), has been identified as an important mediator of CDCA-dependent regulation of gene expression (11, 12).”
BackgroundBile acid dysmetabolism in the gut‐microbiota‐liver axis under hepatitis C virus infection
Inoue, T., Funatsu, Y., Ohnishi, M., Isogawa, M., Kawashima, K., Tanaka, M., Moriya, K., Kawaratani, H., Momoda, R., Iio, E., et al. (2021) · Liver International · doi:10.1111/liv.15041 · Cited by 26
Lu, Y., Hu, L., Song, J., Wan, J., Chen, H., & Yin, J. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00899-z · Cited by 27
Liu, Y., Zhang, S., Deng, H., Chen, A., & Chai, L. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.160849 · Cited by 24
He, X., Gao, X., Hong, Y., Zhong, J., Li, Y., Zhu, W., Ma, J., Huang, W., Li, Y., Li, Y., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c02909 · Cited by 24
Glucagon‐Like Peptide‐2 Alters Bile Acid Metabolism in Parenteral Nutrition–Associated Liver Disease
Lim, D. W., Wales, P. W., Mi, S., Yap, J. Y. K., Curtis, J. M., Mager, D. R., Mazurak, V. C., Wizzard, P. R., Sigalet, D. L., & Turner, J. M. (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115595596 · Cited by 23
Xenohormetic, hormetic and cytostatic selective forces driving longevity at the ecosystemic level
Goldberg, A. A., Kyryakov, P., Bourque, S. D., & Titorenko, V. I. (2010) · Aging · doi:10.18632/aging.100186 · Cited by 27
Schupp, A.-K., Trilling, M., Rattay, S., Le‐Trilling, V. T. K., Haselow, K., Stindt, J., Zimmermann, A., Häussinger, D., Hengel, H., & Graf, D. (2016) · Journal of Virology · doi:10.1128/jvi.00299-16 · Cited by 24
“Primary bile acids are further conjugated with taurine or glycine and secreted into the canaliculi by the bile salt export pump (BSEP), which is located on canalicular membranes of hepatocytes (17, 18).”
BackgroundJia, W. P., & Rajani, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_8 · Cited by 28
(2013) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.s1-002 · Cited by 23
“Bile acids are complex metabolic regulators and signaling factors for governing cholesterol catabolism as well as their own auto-regulation [31,32].”
BackgroundRole of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers
Pallozzi, M., Gaetano, V. D., Tommaso, N. D., Cerrito, L., Santopaolo, F., Stella, L., Gasbarrini, A., & Ponziani, F. R. (2024) · Nutrients · doi:10.3390/nu16142372 · Cited by 27
“Moreover, damage to the plasmatic membrane by toxic BAs triggers protein kinase C (PKC), which, in turn, activates the MAPK cascade, leading to the activation of NF-kB and the production of IL-6, IL-1 beta, and TNF alpha [79,86].”
BackgroundPoulsen, C. B., Al‐Mashhadi, A. L., von Wachenfeldt, K. A., Bentzon, J. F., Nielsen, L. B., Al-Mashhadi, R. H., Thygesen, J., Tolbod, L. P., Larsen, J. R., Frøkiær, J., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.222 · Cited by 26
Kong, Y., Li, M., Wu, X., Xia, C., Liu, X., & Wang, G. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.737845 · Cited by 25
Involvement of Gut Microbial Metabolites Derived from Diet on Host Energy Homeostasis
Nishida, A., Ando, Y., Kimura, I., & Miyamoto, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105562 · Cited by 24
“They were originally thought only to act as soaps that solubilize dietary fats to promote their absorption, but over the past two decades, it has become clear that they act as signaling molecules and bind to distinct receptors such as G-protein coupled bile acid receptor 1 (also known as TGR5) and the bile acid recept…”
BackgroundGut microbiota and fecal metabolic signatures in rat models of disuse-induced osteoporosis
Qiao, X., Zhang, K., Li, X., Lv, Z., Wei, W., Zhou, R., Yan, L., Pan, Y., Yang, S., Sun, X., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1018897 · Cited by 22
“The functional roles of bile acids as key pleiotropic signaling mediators in metabolism and inflammation have been identified through the discovery of the G protein-coupled bile acid receptor TGR5, farnesoid X receptor, vitamin D receptor (VDR), and pregnane X receptor (Thomas et al., 2008; de Aguiar Vallim et al., 20…”
BackgroundGao, M., Chen, M., Chen, Q., Zhu, S., Wang, H., Yang, W., Wang, X., Wang, Q., & Gu, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1131256 · Cited by 24
“Frontiers in Endocrinology 06 and signaling factors (23).”
BackgroundHoff, J. S., Xiong, L., Kammann, T., Neugebauer, S., Micheel, J., Ghait, M., Deshmukh, S. D., Gaßler, N., Bauer, M. W., & Press, A. T. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05794-0 · Cited by 26
“Bile acids are endogenously actively uptaken through highly specialized baso-lateral transporters in Hepatocytes, such as NTCP and OATPs [94].”
Wang, Z., Ding, L., Liu, J., Savarin, P., Wang, X., Zhao, K., Ding, W., & Hou, Y. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105899 · Cited by 26
Wang, J., Zang, J., Yang, Y., Liu, Y., Cao, H., Guo, R., Zhang, L., Liu, M., Zhang, Z., Li, X., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1426049 · Cited by 30
“CYP7A1, CYP8B1, SREBP-1C and SHP were obtained from ThermoFisher Co., Ltd (Shanghai, China).”
BackgroundInfluentialBrossard, D., Lechevrel, M., Kihel, L. E., Quesnelle, C., KHALID, M., Moslemi, S., & Reimund, J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.080 · Cited by 22
Rafferty, E. P., Wylie, A. R., Hand, K. H., Elliott, C. E., Grieve, D. J., & Green, B. D. (2011) · Biological Chemistry · doi:10.1515/bc.2011.050 · Cited by 22
“TGR5 is highly expressed in the gall bladder, jejunum, ileum and colon (Thomas et al., 2008).”
BackgroundPedò, M., D’Onofrio, M., Ferranti, P., Molinari, H., & Assfalg, M. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22496 · Cited by 22
Sarfaraz, M. O., Myers, R. P., Coffin, C. S., Gao, Z., Shaheen, A. A., Crotty, P., Zhang, P., Vogel, H. J., & Weljie, A. M. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0109-2 · Cited by 22
“Additional file tables and figures. human immunodeficiency virus; F: fibrosis; A: necroinflammation; CHREB: conjoint health research ethics board; ALT: alanine‑aminotransferase; AST: aspartate‑aminotransferase; BMI: body mass index; NAFLD: non‑alcoholic fatty liver disease; PCA: principal component analysis; OPLSDA: o…”
BackgroundInfluentialJenniskens, M., Güiza, F., Oorts, M., Perre, S. V., Derde, S., Dufour, T., Thiessen, S., Annaert, P., den Berghe, G. V., & Langouche, L. (2017) · Shock · doi:10.1097/shk.0000000000001001 · Cited by 27
“While BA are currently explored as promising new drug targets for metabolic diseases, their role and regulation in the course of critical illness is not well investigated (26, 27).”
BackgroundNew intercellular lipid mediators and their GPCRs: An update
Im, D. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.01.002 · Cited by 24
Liu, Z., & You, C. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120004 · Cited by 25
Darmanto, A. G., Yen, T., Jan, J., Linh, T. T. D., Taliyan, R., Yang, C. H., & Sheu, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107564 · Cited by 25
Increased atherogenicity in mood disorders: a systematic review, meta-analysis and meta-regression
Jirakran, K., Almulla, A. F., Jaipinta, T., Vasupanrajit, A., Jansem, P., Tunvirachaisakul, C., Dzhambazova, E., Stoyanov, D., & Maes, M. H. J. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106005 · Cited by 24
Liu, J., Jing, C., Guo, Y., Shang, Z., Zhang, B., Zhou, X., Zhang, J., Lian, G., Tian, F., Li, L., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06656-3 · Cited by 29
“In intestinal L cells, activation of TGR5 promotes the secretion of GLP-1, which is crucial for regulating glucose metabolism and insulin secretion [67].”
Nuclear Hormone Receptors as Therapeutic Targets
Levi, M., Wang, X., & Choudhury, D. (2011) · Contributions to nephrology · doi:10.1159/000325668 · Cited by 21
Bile Secretion and the Enterohepatic Circulation
Dawson, P. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00064-0 · Cited by 24
Zhang, X., Liu, X., Yang, J., Ren, F., & Li, Y. (2022) · Metabolites · doi:10.3390/metabo12070633 · Cited by 24
“Fecal BAs act as important biomarkers and signaling molecules in several studies because of the complex interplay between BAs and gut microbiota [9,10].”
BackgroundWupperfeld, D., Fricker, G., Fer, B. B. D., Frank, L., Wehrle, A., & Popovic, B. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01698-8 · Cited by 24
The human microbiome: A promising target for lung cancer treatment
Sun, Y. H., Wen, M., Liu, Y., Wang, Y., Jing, P., Gu, Z., Jiang, T., & Wang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1091165 · Cited by 30
“metabolic homeostasis, and these unbound bile acids activate bile acid signaling receptors (71, 72).”
BackgroundCui, Y., Jing, C., Yue, Y., Ning, M., Chen, H., Yuan, Y., & Yue, T. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300301 · Cited by 29
Huang, W., Wang, J., Kuang, M., Xiao, Z., Fan, B., Sun, G., & Tan, Z. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1271473 · Cited by 26
“The interaction between the IM and BAs plays multiple roles in controlling glucose and lipid metabolism, energy balance, and obesity related pathways through the FXR-mediated regulation of BA signaling (Thomas et al., 2008; Wang et al., 2008; Giannini et al., 2022).”
BackgroundVivian, D., Cheng, K., Khurana, S., Xu, S., Kriel, E. H., Dawson, P. A., Raufman, J., & Polli, J. E. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400740c · Cited by 21
Chen, M.-C., Chen, Y., Wang, T.-W., Hsu, H., & Lai, M.-D. (2016) · Oncology Reports · doi:10.3892/or.2016.5011 · Cited by 24
Mercer, K. E., Bhattacharyya, S., Diaz-Rubio, M. E., Piccolo, B. D., Pack, L., Sharma, N., Chaudhury, M., Cleves, M. A., Chintapalli, S. V., Shankar, K., et al. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy038 · Cited by 21
“In the ileum, reabsorbed bile acids activate FXR, thus increasing transcriptional expression of FGF19 (21, 38).”
BackgroundInfluentialUrso, A., D’Ovidio, F., Xu, D., Emala, C. W., Bunnett, N. W., & Perez‐Zoghbi, J. F. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00242.2019 · Cited by 20
Lamazière, A., Rainteau, D. P., Pukar, K. C., Humbert, L., Gauliard, E., Ichou, F., Ponnaiah, M., Bouby, N., Salem, J., Mallet, J., et al. (2020) · Nutrients · doi:10.3390/nu12113545 · Cited by 22
Bile Acid Toxicity and Protein Kinases
Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_9 · Cited by 23
Yan, S., Liu, S., Qu, J., Li, X., Hu, J., Zhang, L., Liu, X., Li, X., Wang, X., Wen, L., et al. (2022) · Nutrients · doi:10.3390/nu14030560 · Cited by 21
“The classical pathway is induced by 7a-hydroxylation of cholesterol under the action of the CYP7A1 enzyme [61].”
BackgroundLi, Y., Wang, K., Ding, J., Sun, S., Ni, Z., & Yu, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.954684 · Cited by 23
“in some inflammation-related diseases and cancers (Thomas et al., 2008; Jia et al., 2018).”
Han, P., Tian, X., Wang, H., Ju, Y., Sheng, M., Wang, Y., & Cheng, D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128500 · Cited by 21
Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy
Nenkov, M., Shi, Y. H., Ma, Y., Gaßler, N., & Chen, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010006 · Cited by 24
“The inhibition of FXR by FXR shRNA or guggulsterone, an antagonist of FXR, suppressed tumor cell viability and induced apoptosis in vitro and reduced tumor growth in nude mouse xenografts, indicating an oncogenic function of FXR [109].”
BackgroundFeng, X., Deng, M., Zhang, L., & Pan, Q. (2023) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2023-0116 · Cited by 23
Xing, C., Zhang, X., Wang, D., Chen, H., Gao, X., Sun, C., Guo, W., Roshan, S., Li, Y., Hang, Z., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.047 · Cited by 21
Cogliati, C., Ragona, L., D’Onofrio, M., Günther, U. L., Whittaker, S. B. ‐., Ludwig, C., Tomaselli, S., Assfalg, M., & Molinari, H. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201000498 · Cited by 20
Zagorova, M., Prašnická, A., Kadová, Z., Doleželová, E., Kazdová, L., Cermanová, J., Rozkydalová, L., Hroch, M., Mokrý, J., & Mičuda, S. (2015) · Physiological Research · doi:10.33549/physiolres.933206 · Cited by 20
Lemberger, U. J., Fuchs, C. D., Karer, M., Haas, S., Stojaković, T., Schöfer, C., Marschall, H., Wrba, F., Taketo, M. M., Egger, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13521 · Cited by 22
“In parallel to enterocytes in the terminal ileum, proximal convoluted tubule cells express Asbt at the luminal membrane for reabsorption of filtrated bile acids [34].”
BackgroundLC-MS/MS Analysis of Bile Acids
Krautbauer, S., & Liebisch, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7592-1_8 · Cited by 21
Wang, X., Wang, F., Zhang, Y., Xiong, H., Zhang, Y., Zhuang, P., & Zhang, Y. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.01.006 · Cited by 20
Matysik, S., Krautbauer, S., Liebisch, G., Schött, H.-F., Kjølbæk, L., Astrup, A. V., Blachier, F., Beaumont, M., Nieuwdorp, M., Hartstra, A. V., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15440 · Cited by 20
“As conjugated bile acids must first be de-conjugated by bacterial BSHs to be metabolized into secondary bile acids (Long et al., 2017; Thomas et al., 2008), almost no conjugated secondary bile acids were present in the intestinal content.”
BackgroundTGR5 ligands as potential therapeutics in inflammatory diseases
Pols, T. W. H., Eggink, H. M., & Soeters, M. R. (2014) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s40102 · Cited by 26
“Since then, TGR5 has been investigated in several cell types, such as muscle cells, adipocytes, endothelial cells (ECs), and macrophages.(1,5) The functions of TGR5, which are dependent on cell type, range from glucagon-like peptide-1 (GLP-1) release and mitochondrial energy homeostasis to the control of inflammatory…”
InfluentialZhang, X., Sui, Z., Kauffman, J. A., Hou, C., Chen, C., Du, F., Kirchner, T., Liang, Y. T., Johnson, D. L., Murray, W. V., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.02.069 · Cited by 20
Bile acid‐activated receptors in innate and adaptive immunity: targeted drugs and biological agents
Cheung, K. C. P., Ma, J., Loiola, R. A., Chen, X., & Jia, W. P. (2023) · European Journal of Immunology · doi:10.1002/eji.202250299 · Cited by 24
Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease
Li, W., Gao, W., Yan, Q. S., Yang, L., Zhu, Q., & Chu, H. (2024) · Biomedicines · doi:10.3390/biomedicines13010074 · Cited by 22
“Takeda G protein-coupled receptor 5 (TGR5, also known as GPBAR1) is another bile acid-responsive receptor present on various cells, including KC, immune cells, and adipose connective tissue [21,126].”
On the Evolution of Bile Salts and the Farnesoid X Receptor in Vertebrates
Frisch, K., & Alstrup, A. K. O. (2017) · Physiological and Biochemical Zoology · doi:10.1086/695810 · Cited by 18
“…aid in the solution and absorption of dietary lipids in the small intestine, bile salts are today recognized also as hormones controlling a number of physiological functions by interacting with specific nuclear and membrane receptors (Thomas et al. 2008; Halilbasic et al. 2013; Copple and Li 2016).”
BackgroundRecent updates on alcoholic hepatitis
Shipley, L. C., Kodali, S., & Singal, A. K. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.03.023 · Cited by 20
Bileome: The bile acid metabolome of rat
Gaikwad, N. W. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.06.052 · Cited by 23
Hu, R., Zhang, L., Li, Q., Ding, H., Li, R., Gu, W., Chen, R., Zhang, Y., Rajagoplan, S., Zhang, K., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121347 · Cited by 20
Agatić, Z. F., Popović, K. J., Kumar, D., Škorić, D., & Poša, M. (2023) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2023.121682 · Cited by 19
Revisited role of the placenta in bile acid homeostasis
Ontsouka, E. C., Schroeder, M., & Albrecht, C. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1213757 · Cited by 24
“Specifically, internal modifications of CA and CDCA convert them into deoxycholic acid (DCA) and lithocholic acid (3α-hydroxy-5β-cholanoic acid; LCA), respectively.”
BackgroundInfluentialZhu, L., Fang, S., Zhang, H., Sun, X., Yang, P., Wan, J., Zhang, Y., Lu, W., & Yu, L. L. (2023) · Nutrients · doi:10.3390/nu15234929 · Cited by 19
“In addition, primary BAs could be further metabolized into secondary BAs by gut microbiota enzymes in the intestine [9].”
BackgroundWang, Y., Zou, Z., Wang, S., Ren, A., Ding, Z., Li, Y., Wang, Y., Qian, Z., Bian, B., Huang, B., et al. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00912-2 · Cited by 20
“The diminished presence of taurine-conjugated bile acids such as TCA and TDCA in systemic circulation could reflect the diminished efficacy of clearing free bile acids in the liver [41, 42].”
BackgroundChen, L., Zhang, L., Liu, S., Liu, Y.-Q., Ren, G., Wang, T.-Y., Zhang, L., Wang, R., & Liu, B. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01979-23 · Cited by 20
“BAs serve as crucial signaling molecules, exerting significant influence on the body’s energy metabolism and inflammatory response, thereby establishing a strong associa tion with liver diseases (22).”
BackgroundWang, J., Zhong, M.-Y., Liu, Y., Yu, J.-Y., Wang, Y., Zhang, X., & Sun, H. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01417-2 · Cited by 21
“Of interest, emerging evidence demonstrates bile acids are also potent nutrient signaling molecules for glucose, lipid and energy metabolism via dedicated bile acid receptors [11 – 15].”
Disulfide bridge regulates ligand‐binding site selectivity in liver bile acid‐binding proteins
Cogliati, C., Tomaselli, S., Assfalg, M., Pedò, M., Ferranti, P., Zetta, L., Molinari, H., & Ragona, L. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07309.x · Cited by 19
Bakke, A. M., Chikwati, E., Venold, F. F., Sahlmann, C., Holm, H., Penn, M. H., Oropeza-Moe, M., & Krogdahl, Å. (2013) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2013.11.010 · Cited by 23
“, 1971; Harries and Sladen, 1972), although other studies described bile acids' signalling properties, indicating to tissues that feeding has commenced (Houten et al., 2006; Thomas et al., 2008; Pols et al., 2011).”
ResultPoša, M., Bjedov, S., Škorić, D., & Sakač, M. N. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.03.010 · Cited by 19
Shimada, T., Nakanishi, T., Toyama, A., Yamauchi, S., Kanzaki, A., Fujiwake, H., Sato, T., & Ikegawa, M. (2010) · Journal of Proteome Research · doi:10.1021/pr1002388 · Cited by 19
A shift in paradigm towards human biology‐based systems for cholestatic‐liver diseases
Noor, F. (2015) · The Journal of Physiology · doi:10.1113/jp271124 · Cited by 19
“The functional BA pool is maintained by an extended system of transporters (Thomas et al. 2008) as shown in Fig.”
BackgroundGonzález-Peña, D., Dudzik, D., Colina-Coca, C., de Ancos, B., García, A., Barbas, C., & Sánchez‐Moreno, C. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0914-1 · Cited by 19
Hepatic deletion of X-box binding protein 1 impairs bile acid metabolism in mice
Liu, X., Henkel, A. S., LeCuyer, B. E., Hubchak, S. C., Schipma, M. J., Zhang, E. W., & Green, R. M. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m071266 · Cited by 18
“glucose and lipid metabolism in the liver, and regulate energy expenditure in the peripheral tissues (1, 2).”
BackgroundZong, E., Yan, S., Wang, M., Yin, L., Wang, Q., Yin, J., Li, J., Li, Y., Ding, X., Huang, P., et al. (2019) · Journal of Animal Science · doi:10.1093/jas/skz059 · Cited by 19
Li, W., Liu, R., Li, X., Tao, B., Zhai, N., Wang, X., Li, Q., Zhang, Y., Gu, W., Wang, W., et al. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12956 · Cited by 20
“36 Lithocholic acid is the strongest agonist of TGR5, followed by DCA and CA.37 The findings of increases in both primary and secondary bile acids after saxagliptin treatment in the present study may affect FXR or TGR5 signaling to contribute to metabolic improvement.”
BackgroundInfluentialGut Microbiota and Heart, Vascular Injury
Zeng, C., & Tan, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_8 · Cited by 21
Poša, M., Pilipović, A. S., & Lalic-Popovic, M. N. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.07.031 · Cited by 19
Dehmlow, H., Sánchez, R. A., Bachmann, S., Bissantz, C., Bliss, F., Conde‐Knape, K., Graf, M. R., Martin, R. E., Obst-Sander, U., Raab, S., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.06.017 · Cited by 22
Kårhus, M. L., Brønden, A., Sonne, D. P., Vilsbøll, T., & Knop, F. K. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12946 · Cited by 21
“with these characteristics, naturally occurring bile acids may have been overlooked.(2)”
BackgroundZhu, Y., Zhang, K.-X., Bu, Q., Song, S., Chen, Y., Zou, H., You, X., & Zhao, G. (2024) · Phytotherapy Research · doi:10.1002/ptr.8402 · Cited by 19
“In addition, BAs, as signaling molecules and metabolic regulators, are mediated by G- protein-coupled receptor 5 (TGR5) and farnesoid X receptor (FXR) to regulate hepatic lipid homeostasis and maintain metabolic homeostasis (Thomas et al. 2008).”
Zeng, W., Sun, M., Cao, J., Chen, C., Jiang, S., Wang, Y., Yang, W.-Q., Zhao, Z., & Jin, J. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156537 · Cited by 21
Yuan, T., Gao, X., Wang, X., Tang, X., Liang, Z., Yin, Y., Liu, S., Ou, J., Su, W., Zhang, Z., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01238-3 · Cited by 23
“CYP7A1 and CYP8B are the key enzymes for regulating the synthesis of BAs; and Farnesoid X receptor (FXR) serves as a master regulator of BA metabolism [25].”
Bai, Y., Zhao, T., Gao, M. M., Zou, Y., & Lei, X. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00264 · Cited by 22
The association of serum total bile acid with new-onset hypertension during pregnancy
Deng, W., Zhang, L., Du, Q., Li, Y., Chen, J., Du, L., & Chen, D. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-05211-y · Cited by 20
“However, increasing evidence shows that BA can be a signaling molecule that participates in the occurrence of many diseases, including hypertension [11, 12].”
BackgroundJones, R., Lopez, A. M., Tong, E. Y., Posey, K. S., Chuang, J.-C., Repa, J. J., & Turley, S. D. (2014) · Steroids · doi:10.1016/j.steroids.2014.11.002 · Cited by 18
Fiamoncini, J., Barbosa, C. F., Arnoni, J. R., Junior, J. A., Taglieri, C., Szego, T., Gelhaus, B., de Souza, H. P., Daniel, H., & de Lima, T. M. (2018) · Metabolites · doi:10.3390/metabo8040083 · Cited by 20
“Bile acid metabolism is crucial to cholesterol homeostasis and BA modulate metabolic processes through G protein-coupled receptor (TGR5) and nuclear receptors (FXR, LXR and others) [32].”
BackgroundPET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease
Shao, T., Josephson, L., & Liang, S. H. (2019) · Molecular Imaging · doi:10.1177/1536012119871455 · Cited by 19
“Bile acids lead to dysfunction of farnesoid X receptor, liver X receptor, pregnane X receptors, and/ or G-protein-coupled receptor TGR5, which are involved in a variety of metabolic and hepatic functions.(18) Excess bile acids accumulation leads to, in order of increasing severity in liver dysfunction, acute oxidative…”
BackgroundAnti-obesity Effect of Alkaline Reduced Water in High Fat-Fed Obese Mice
Ignacio, R. M. C., Kang, T.-Y., Kim, C.-S., Kim, S., Yang, Y.-C., Sohn, J.-H., & Lee, K. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00781 · Cited by 21
van Nierop, F. S., Kulik, W., Endert, E., Schaap, F. G., Damink, S. W. M. O., Romijn, J. A., & Soeters, M. R. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.10.006 · Cited by 22
“BA are increasingly recognized as pleiotropic hormones with effects on glucose and lipid metabolism, in addition to their role as intestinal emulgators [1].”
BackgroundPoša, M., Pilipović, A. S., Tepavčević, V., & Obradović, S. (2018) · Journal of Chemical & Engineering Data · doi:10.1021/acs.jced.7b00880 · Cited by 17
FXR activation prevents liver injury induced byTripterygium wilfordiipreparations
Peng, W., Dai, M., Bao, L., Zhu, W., & Li, F. (2021) · Xenobiotica · doi:10.1080/00498254.2021.1900626 · Cited by 20
Pacífico, C., Hartinger, T., Stauder, A., Schwartz, H., Reisinger, N., Faas, J., & Zebeli, Q. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.714545 · Cited by 17
Lin, X., Zhu, X., Xin, Y., Zhang, P., Xiao, Y., He, T., & Guo, H. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200595 · Cited by 19
Guo, D., Chen, Q., Wang, G., & Li, C. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1190866 · Cited by 17
Jirakran, K., Vasupanrajit, A., Tunvirachaisakul, C., Almulla, A. F., Kubera, M., & Maes, M. H. J. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06734-2 · Cited by 18
“The comorbidity of MetS with mood disorders associates with a more intricate affective presentation, diminished recovery prospects, and an elevated incidence of episodes and suicide attempts [16, 18, 22, 71].”
Metadata
- Authors
- Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K.
- Affiliations
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- University of Perugia (IT)
- Intercept Pharmaceuticals (United States) (US)
- Corresponding author
- Auwerx, Johan
- Schoonjans, Kristina
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-08
- Volume
- 7
- Issue
- 8
- Pages
- 678-693
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2078810890
- Cited by
- 1,422
- References
- 169
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 106 · 2023: 107 · 2022: 113 · 2021: 90 · 2020: 83 · 2019: 82 · 2018: 78 · 2017: 81 · 2016: 75 · 2015: 75 · 2014: 71 · 2013: 77 · 2012: 47
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- European Commission
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Société Française de Nutrition
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Keywords
- bile acids, bile acid signaling, metabolic disorders, obesity, type 2 diabetes, hypertriglyceridemia, atherosclerosis, nonalcoholic steatohepatitis, therapeutic target, drug development
- MeSH terms
- Animals, Bile Acids and Salts, Humans, Metabolic Diseases, Signal Transduction, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.